The potential of obidoxime and other pyridinium-4-aldoximes to reactivate d
imethyl- and diethylphosphorylated cholinesterases is markedly restricted b
y the inevitable formation of rather stable phosphoryl oximes (POXs) with h
igh anticholinesterase activity. This effect is hardly seen with very dilut
e enzyme preparations, but becomes significant at physiological enzyme conc
entrations. Human plasma with the butyrylcholinesterase irreversibly blocke
d by soman was able to stimulate obidoxime-induced reactivation of concentr
ated erythrocyte acetylcholinesterase (Ery-AChE) to the saline extent as wa
s observed with a dilute preparation, suggesting phosphoryl oxime-destroyin
g capacity. The inactivating factor, which was tentatively termed POX-hydro
lase, had (1) a molecular weight of >100 kDa; (2) required Ca2+, which coul
d not be substituted by Zn2+ or Mg2+ ; and (3) lost its catalytic activity
reversibly ill the presence of ethylenediaminetetraacetic acid (EDTA). The
enzyme activity varied widely (20-fold) among different subjects and did no
t follow the activity pattern of human serum paraoxonase (PONI). Rabbit pla
sma with its particularly high paraoxonase content showed only weak POX-hyd
rolase activity. These data suggest POX-hydrolase to be a different entity.
POX-hydrolase was most active with the putative phosphoryl-obidoxime from
paraoxon-ethyl, less with the product from paraoxon-methyl and least with t
hat from diisopropylfluorophosphate. The analogue TMB-4 reacted similarly t
o obidoxime. The putative phosphonyl oximes arising by the reaction of obid
oxime with nerve agents were apparently not cleaved. The variation in POX-h
ydrolase activity may additionally contribute to the variable response to o
xime therapy in patients with organophosphate insecticide poisoning.